Publishing research using ab78318? Please let us know so that we can cite the reference in this datasheet.

ab78318 has been referenced in 11 publications.

  • Han H  et al. microRNA-206 impairs c-Myc-driven cancer in a synthetic lethal manner by directly inhibiting MAP3K13. Oncotarget 7:16409-19 (2016). PubMed: 26918941
  • Myant K  et al. Serine 62-Phosphorylated MYC Associates with Nuclear Lamins and Its Regulation by CIP2A Is Essential for Regenerative Proliferation. Cell Rep 12:1019-31 (2015). PubMed: 26235622
  • Cianfanelli V  et al. AMBRA1 links autophagy to cell proliferation and tumorigenesis by promoting c-Myc dephosphorylation and degradation. Nat Cell Biol 17:20-30 (2015). PubMed: 25438055
  • Kauko O  et al. Label-free quantitative phosphoproteomics with novel pairwise abundance normalization reveals synergistic RAS and CIP2A signaling. Sci Rep 5:13099 (2015). WB . PubMed: 26278961
  • Ischenko I  et al. Analysis of the tumor-initiating and metastatic capacity of PDX1-positive cells from the adult pancreas. Proc Natl Acad Sci U S A 111:3466-71 (2014). PubMed: 24550494
  • Mannava S  et al. PP2A-B56a controls oncogene-induced senescence in normal and tumor human melanocytic cells. Oncogene 31:1484-92 (2012). PubMed: 21822300
  • Tibbitts DC  et al. Studying c-Myc serine 62 phosphorylation in leukemia cells: concern over antibody cross-reactivity. Blood 119:5334-5 (2012). PubMed: 22653959
  • Tsai WB  et al. Activation of Ras/PI3K/ERK pathway induces c-Myc stabilization to upregulate argininosuccinate synthetase, leading to arginine deiminase resistance in melanoma cells. Cancer Res 72:2622-33 (2012). PubMed: 22461507
  • Chung EY  et al. CD19 is a major B cell receptor-independent activator of MYC-driven B-lymphomagenesis. J Clin Invest 122:2257-66 (2012). PubMed: 22546857
  • Kapeli K & Hurlin PJ Differential Regulation of N-Myc and c-Myc Synthesis, Degradation, and Transcriptional Activity by the Ras/Mitogen-activated Protein Kinase Pathway. J Biol Chem 286:38498-508 (2011). WB . PubMed: 21908617
  • Junttila MR  et al. CIP2A inhibits PP2A in human malignancies. Cell 130:51-62 (2007). PubMed: 17632056

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up